Description: Presented at September 1994 Valuation Actuary Symposium. This session presents the approaches of a stock and a mutual company to surplus management, and the application of recent research in risk theory to surplus management.

Description: From the Record 1977 Vol. 3, No. 1, this presentation is from a concurrent session at the Society of Actuaries 1977 Regional Meeting, held in Atlanta March 31-April 1. The presenters at this session discuss the sources of funds for stock life insurance companies, including debt, capital, policyholders, and coinsurance, and the prioritization of the use of funds. “Enterprise risk exposure and management” and policyholder vs. shareholder dividend philosophy are additional topics.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Presented at May 1985 Spring Meeting. This session discussed: Relationship of pricing and valuation actuaries in Canada, Financial reporting system as an information source for product development, Interaction of the pricing actuary, valuation actuary, and investment officer in designing interest-sensitive products, Allocation impact on product development of expense, investment income, tax, and capital, Financial reporting information in changing premium rates for nonguaranteed premium products, Maintaining consistency between pricing and financial projection models, Reserve basis and nonforfeiture basis impact on product development, with special reference to lapse-sensitive products.

Description: This panel of session 3PD of the Washington Annual Meeting discusses a range of topics which fall under a new professional label of financial engineer, and how this role relates to the role of the actuary. From the Record of the Society of Actuaries, Vol. 23, No. 3.

Description: Panel discusses securitization as a popular method for improving returns and clearing up balance sheets. From the Record of the Society of Actuaries, Vol. 23, No. 3., Session 74 PD of the Washington Annual Meeting

Description: From a session at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999 Equity-indexed products require an asset strategy that matches the equity options embedded in the liability. The panel discusses the following: A. Two asset strategies 1. Purchasing equity options that match the liability options: Is this a perfect match or are there still unhedged risks? 2. Dynamic hedging using the mathematics of “the Greeks”: Is it self-insuring? B. Accounting issues with these strategies

Description: One important lesson learnt from the recent financial crisis was that overreliance on financial models could lead to unforeseen and harmful consequences. Model risk management (MRM) is becoming a core and mandatory component in enterprise risk management for many financial institutions, especially Fed/OCC CCAR-compliant firms. In recent years, insurance companies are also being required to have model risk management programs by Solvency II, ORSA and other supervisory guidance. MRM is not just model validation. It consists of governance and policies regarding a model's life cycle including data, model development, model test and implementation, model validation, model monitoring and documentation. It also provides guidelines and standards for risk assessment and model inventory management. The presenters will discuss current and best practice MRM, approach for model validation and auditing, as well as topics for technical issues such as types of model risks. It will also discuss the differences between Fed/OCC standards and Solvency II standards. At the conclusion of the session, attendees will be able to: Describe best practice in model risk management; Explain requirements and standards; and Develop model validation procedure.

Description: Presented at October 1986 Annual Meeting. This session discussion is about how capital should be measured, cash flow based surplus, what performance measures are reliable, return on equity, book gains, terminal funds, how much surplus is needed, business planning for future capital needs, capital restructuring, how should multiple risks be combined and qualitative issues versus numbers as they relate to future growth.

Description: This session discussion is about various asset related items that are needed to perform necessary projections. From Record of the Society of Actuaries Vol. 15, No. 2.